One of the first activities in drug development is developing a therapeutic hypothesis and target identification. During this process, researchers need to develop an understanding of the disease pathology, existing targets, and associated pathways. A full understanding of the existing chemical landscape, and how a drug is likely to respond in humans, is also essential to developing the best possible research strategy.
From metabolic pathways and unparalleled OMICs data analysis to the most current and reliable biomarkers intelligence, animal models, experimental pharmacological information, and pharmacokinetics data, we can support you with rapid access to reliable information and our scientific experts and specialists to support you from the very start of your research.
We can help you:
- Identify which companies have exploited a target-disease association
- Assess the drugs that are in the pipeline for a particular therapy area or mechanism of action
- Identify key market, regulatory, science and technology trends and insights that may affect the company’s internal portfolio
- Understand what is the freedom to operate